nkp-1339
Small moleculeexperimental
Clinical trial activity
1 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Oct 1, 2009 (NCT01415297)
Timeline
2000s
- Jan 1, 2009
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
ATP4B unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- nkp-1339
- nkp-1339
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01415297 | Phase 1 | Oct 1, 2009 | Niiki Pharma Inc., SCRI Development Innovations, TGen Drug Development |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Niiki Pharma Inc. | For profit | 1 | 1 | 1 | 2009 |
| SCRI Development Innovations | For profit | 1 | 0 | 1 | 2009 |
| TGen Drug Development | Academic/Hospital | 1 | 0 | 1 | 2009 |
3 organizations
Page 1 / 1